LL-37
Peptide therapy: benefits, side effects, cost and protocols
C205H340N60O53
LL-37 (cathelicidin) is a 37-amino acid antimicrobial peptide encoded by the CAMP gene in humans. It is the active form of the precursor CAP-18, processed by proteinase 3-mediated cleavage. It plays key roles in innate immune defense against bacterial, viral, and fungal infections.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Banned from Compounding March 2024 Not eligible for compounding. Antimicrobial peptide removed from nomination list.
- Evidence
- Moderate Evidence
Who it's for
Who LL-37 is usually considered for
- Wound healing
- Antimicrobial activity
- Immune modulation
- Limited human trials or strong preclinical
Mechanism
How LL-37 works
Human cathelicidin that exhibits broad-spectrum antimicrobial activity while promoting wound healing and immune response.
Evidence
Key studies
2,565 papers on PubMed
- 01
Efficacy and safety of Oral LL-37 against the Omicron BA.5.1.3 variant of SARS-COV-2: A randomized trial
- 02
Zhao Y, Zhang H, Zhao Z et al
J Med Virol / Phase 2
- 03
Oral LL-37 demonstrated efficacy and safety against Omicron BA.5.1.3 SARS-CoV-2 variant
- 04
The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12(®) in infant colic: A randomised, double blind, placebo-controlled trial
- 05
Nocerino R, De Filippis F, Cecere G et al
Aliment Pharmacol Ther / Aliment Pharmacol Ther / RCT
- 06
Bifidobacterium animalis BB-12 showed therapeutic efficacy in infant colic
- 07
Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial
- 08
Grönberg A, Mahlapuu M, Ståhle M et al
Wound Repair Regen / Wound Repair Regen / Phase 2
- 09
LL-37 treatment is safe and effective in enhancing healing of hard-to-heal venous leg ulcers
- 10
Serum LL-37 and inflammatory cytokines levels in psoriasis
Compound
LL-37 compound data
- Formula
- C205H340N60O53
- Mol. weight
- 4493 g/mol
- PubChem CID
- 16198951 ↗
- IUPAC
- (4S)-5-[[(1S)-5-amino-1-[[(1S,2S)-1-[[2-[[(1S)-5-amino-1-[[(1S)-1-[[(1S)-2-[[(1S)-5-amino-1-[[(1S)-1-[[(1S,2S)-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S,2S)-1-[[(1S)-5-amino-1-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-3-amino-1-[[(1S)-1-[[(1S)-1-[(2S)-2-[[(1S)-1-[[(1S,2R)-1-[[(1S)-3-carboxy-1-[[(1S)-1-carboxy-2-hydroxy-ethyl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-guanidino-butyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-oxo-propyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-1-benzyl-2-oxo-ethyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]pentyl]carbamoyl]-2-methyl-butyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-4-oxo-butyl]carbamoyl]-2-methyl-propyl]carbamoyl]-2-methyl-butyl]carbamoyl]-4-guanidino-butyl]carbamoyl]pentyl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]pentyl]amino]-2-oxo-ethyl]carbamoyl]-2-methyl-butyl]carbamoyl]pentyl]amino]-4-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-amino-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]acetyl]amino]-3-carboxy-propanoyl]amino]-3-phenyl-propanoyl]amino]-3-phenyl-propanoyl]amino]-5-guanidino-pentanoyl]amino]hexanoyl]amino]-3-hydroxy-propanoyl]amino]hexanoyl]amino]-5-oxo-pentanoic acid
FAQ
LL-37 questions
What is LL-37?
LL-37 is a naturally occurring antimicrobial peptide (cathelicidin) researched for wound healing, antimicrobial activity, and immune modulation.
How does LL-37 work?
Human cathelicidin that exhibits broad-spectrum antimicrobial activity while promoting wound healing and immune response.
Is LL-37 legal to buy?
LL-37 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy LL-37?
LL-37 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does LL-37 belong to?
LL-37 is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.
What are the research benefits of LL-37?
LL-37 has been studied for: Wound healing, Antimicrobial activity, Immune modulation. Wound healing + antimicrobial; human defensin peptide.
News
LL-37 in the news
Antimicrobial peptide LL-37 promotes proliferation of human bone marrow-derived mesenchymal stem cells - Nature
Nature / 3 months ago
Engineered Hybrid Peptide Neutralizes Bacterial Endotoxin and Combats Poultry Pathogens - Bioengineer.org
Bioengineer.org / 4 days ago
Human cathelicidin peptide LL-37 compacts nucleic acids and alters neutrophil extracellular trap structure - Nature
Nature / 6 months ago
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation - ASM Journals
ASM Journals / 45 months ago
Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy - Frontiers
Frontiers / 51 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering LL-37?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.